Purpose: To present a review supporting and refuting evidence from mouse, rabbit, nonhuman primate, and human studies of herpes simplex virus type 1 (HSV-1) concerning corneal latency.
H erpes simplex virus type I (HSV-1) DNA has been found in the corneas of patients with chronic herpetic keratitis (HK), [1] [2] [3] [4] [5] the tears of asymptomatic patients, [6] [7] [8] [9] [10] and in the eye bank corneas. [11] [12] [13] Three possible explanations for the presence of this DNA in human corneas are operational latency, persistent low-grade infection, and neuronal reactivation of latent HSV. In humans, HSV infection occurs early in life and can be either symptomatic or asymptomatic. Symptomatic infection generally produces ulcerative lesions on a superficial body surface such as the skin or the cornea. Asymptomatic infection involves the retrograde transport of the virus from the nerves at the site of contact to a ganglion in the absence of lesions. The virus remains in the neurons as intact quiescent viral genomes without any obvious pathological effects, a state known as latency (see Table 1 for a list of definitions and references that support the concepts).
HSV can reactivate from a ganglion and travel by anterograde transport to any site in the distribution of that ganglion. This results in the shedding of viral DNA/infectious virus (enveloped HSV virions capable of host cell invasion, replication, cell lysis, and release of infectious progeny, Table 1 ), which results in herpetic lesions in some individuals. HSV-1 is generally accepted to become latent in neuronal sites, such as the trigeminal ganglion (TG). However, nonneuronal sites of latency, such as the cornea, have also been proposed. 20, 22, 23 HSV-1 DNA and infectious HSV-1 (used interchangeably with infectious virus) have been found repeatedly in the corneas of latently infected hosts. 5, [11] [12] [13] 16, 17, 21, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] However, the concept of HSV-1 corneal latency has failed to gain universal acceptance because of the difficulty in proving that the cornea is truly a reservoir for the virus rather than a fast pit stop (transient site) along the exit path from a sensory ganglion. There are 3 main possibilities to explain the presence of HSV-1 in the cornea. These comprise (1) operational latency, which in an animal model is characterized by the immediate absence of infectious virus in the cornea or in the TG at the time of sacrifice and the capacity of the excised cornea or TG to produce infectious virus in the cornea after a period of time; (2) persistent low-grade infection, which is characterized by viral replication and release of infectious progeny in such small numbers that infectious virus cannot be easily detected by currently available methods, and no clinical lesions are apparent; and (3) neuronal reactivation with downstream shedding, which refers to infectious virus/HSV-1 DNA that originates in the neuron but travels to the cornea by anterograde transport.
Human studies have demonstrated that HSV DNA shedding is an ongoing process in the head and neck region and possibly in the genital region as well. 6, 24, 34, 35 Thus, latency is not absolute because viral replication denoting the production of infectious virus can be missed by the available detection methods because of their very limited sensitivity. Cell culture, a commonly used technique to detect infectious virus, has been shown to have a sensitivity of 2% or less for the detection of HSV-1. 36 Although it may not be plausible to definitively prove corneal latency, it is important to study HSV-1 corneal shedding and the possibility of the existence of corneal latency. A better knowledge and understanding of the disease state at the time of corneal transplantation could give rise to more effective treatment and help to reduce the incidence of HSV-related graft failure after penetrating keratoplasty (PKP). 22 Also, the cornea is a relatively accessible tissue, and a more detailed evaluation of HSV disease stages and progression can be accomplished through in vivo studies if corneal latency is proven.
SENSITIVITIES OF DETECTION METHODS
Before discussing the various studies supporting or refuting HSV corneal latency, it is pertinent to review the strengths and limitations of the tests used to detect HSV-1 DNA and infectious HSV-1. The most sensitive test to detect HSV-1 DNA is the polymerase chain reaction (PCR) with a sensitivity of 82% and a specificity of 78%. 36 PCR is 1000-10,000 times more sensitive than the serology assay for HSV-1 antibody. 14 Immunohistochemistry detects HSV-1 antigen with a sensitivity of 74% and a specificity of 85%. 36 PCR detects the presence of specific segments of the HSV-1 genome and does not imply the presence of the entire genome. PCR does not detect infectious virus, and there is not a direct relationship between the HSV-1 DNA copy numbers and infectious progeny in these tests.
Although cell cultures are the ''gold standard'' for the detection of the presence of infectious virus, they have a very low The genetic material of HSV-1.
LAT
The only region of the HSV-1 genome abundantly transcribed during latency. Not required for latency but is a marker for latency. 16 Genetic material shed through bodily fluids of an asymptomatic individual. 6, 14 sensitivity for detecting HSV-1 compared with PCR assays. 17, 36 One of the reasons for the low sensitivity of cell cultures is the fragility of infectious HSV-1. The lipid envelope is easily disrupted, and a broken envelope renders the virus noninfectious and unable to replicate in cell cultures. Electron microscopy can be used to physically observe viral structures, but has unknown sensitivity, is subject to sampling errors, and provides no information on infectivity.
VIRAL FACTORS AND THEIR RELEVANCE TO LATENCY
The latency-associated transcript (LAT) is an RNA transcript from the antisense strand that overlaps part of an immediate early gene (ICP-0) of the HSV-1 genome and is suggested to perform several functions, including the inhibition of neuronal apoptosis and the enhancement of reactivation. 15, 17, 24, [37] [38] [39] LAT has been detected in HSV-1 infected cells during both the replicating (lytic) and nonreplicating (latent) stages of infection. 17, 39, 40 Although LAT is not required to establish latency, 15, 37, 38, 41, 42 it is the only abundantly transcribed viral gene during latency and is a known molecular marker for viral latency. 17 Thus, the presence of LAT in a tissue is commonly used as evidence of HSV-1 latency in that tissue. However, the absence of LAT is not an indication that either the tissue or the cell does not have HSV-1 DNA. In situ hybridization studies of LAT and in situ hybridization studies of HSV-1 DNA have shown that not all latent cells have detectable LAT. 24, 39, 40 Furthermore, studies of deletion viruses that do not transcribe LAT are HSV-1 DNA positive. 24, 40 
MOUSE STUDIES
HSV infection has been extensively studied in mice (Table 2 ) because of the low cost and the availability of different strains of mice. The availability of different mouse strains allows researchers to examine disease progression in genetically specified environments. However, the widespread use of different mouse strains also makes it difficult to relate studies of 1 mouse strain to studies of a different mouse strain and to studies of other animals.
Nonetheless, the concept of nonneuronal latency was first proposed in mouse studies regarding HSV skin infection in 1979. 18 Hill et al 18 isolated infectious HSV-1 (strain SC-16) from 7 of 88 ears (8%) of latently infected female Swiss white mice (noninbred), which received no stimulation and from 9 of 31 mice (29%) whose ears were stimulated with cellophane tape 4 days before sacrifice. However, the authors failed to report on the origin of the detected virus, which could have come from the ear or the ganglion that innervated the ear.
In addition to the recovery of HSV-1 from the skin, the virus has also been isolated from the eyes of latently infected mice. Abghari and Stulting 25 found infectious HSV-1 (strain STU-4) by culture in 20% (2 of 10) of the eyes and in 18% (3 of 17) of the corneas of 6-to 8-week-old mice (DBA/2, BALB/c, and C57BL/6). This study also reported that infectious HSV-1 was isolated considerably later from corneal cultures than from TG cultures. 25 Possible explanations for the delay in viral growth could be related to mechanical trapping after reactivation, differences in the process of reactivation in 2 different tissues, or the number of latent foci in each tissue. This growth delay seen in nonneuronal sites favors corneal latency, as virus from a persistent infection or viral shedding from the TG (or other 43 reported the percent of neurons positive in TGs was approximately 7.35% (range: 1%-30%) and the copy numbers of HSV-1 DNA per neuron ranged from 10 to 1000. †Sawtell et al 44 reported the low phenotypic reactivator of HSV-1 strain KOS/M compared with 17Syn+, a high phenotypic reactivator. ganglia) would be expected to grow at a faster rate because replication could begin immediately without the need for reactivation or neuronal anterograde transport. 27 Abghari et al 16 showed the presence of LAT in 25% (5 of 20) and the presence of ICP-0 (HSV-1 strain STU-4) in 3% (1 of 34) of the specimens taken from latently infected 6-to 8-week-old BALB/c mouse corneas by in situ hybridization. This study showed the absence of infectious virus by cell-free and homogenized cell cultures at the time of sacrifice, which were all negative. A possible source of error in the study was that each specimen used for culture was obtained from 2 corneas. One might argue that LAT in each positive specimen could reflect the presence of ICP-0 in one of the corneas, but the disparity in positive specimens (25% vs. 3%) makes this possibility unlikely. 16 Keep in mind that the viral genomic regions for ICP-0 and LAT overlap and are on opposing strands of the viral DNA. 19, 40 Evidence refuting corneal latency comes from studies that fail to demonstrate reactivation and infectious HSV-1 in the cornea. Easty et al 3 showed that HSV-1 (strain SC-16) did not persist in the anterior segment of NIH strain mice (noninbred) when inoculated directly into the cornea. However, Bristol/2 mice (noninbred) inoculated in the snout did have persistent virus isolated from 8 of the 20 corneas (40%) tested. 3 These findings suggest that either the sensory ganglion is required to establish latency in stromal keratocytes or that the virus thought to be reactivated from the cornea was actually reactivated from the ganglion.
The strain of mouse has been shown to affect the rate of reactivation in mice infected with LAT-positive recombinants of HSV-1. 40 Perng et al 38, 39 reported that BALB/c mice showed no significant difference in reactivation when infected with LAT-positive and LAT-negative strains. However, Swiss Webster mice infected with a LAT-negative strain showed a significant decrease in reactivation when compared with those infected with a LAT-positive strain. 40 The finding that different mouse strains react differently to viral infection, coupled with the wide variation among mouse strains used for HSV studies, complicates the comparison of mouse studies to those of other animals.
Sawtell et al 44 have shown that after corneal inoculation in mice, HSV-1 strains can exhibit different rates (high versus low) of reactivating in response to hyperthermia. The HSV-1 strain of 17Syn+ had a high reactivation frequency in mouse tears. A lower reactivation frequency of HSV-1 strain KOS/M ( Table 2 ) was shown. Sawtell 43 assessed individual neurons for HSV DNA copy numbers and reported a wide variation of 10-1000 copies per neurons for the mouse TG. Also, the percent of neurons positive for HSV-1 DNA in the mouse TG latent with 17Syn+ averaged 7.35% with the range of 1%-30% (Table 2 ). These studies demonstrate that 1 mouse neuron can be assessed with the lower limit of detection at approximately 10 copies of HSV-1 DNA. In summary, the different mouse strains have shown varied responses to different strains of HSV, 40 making it difficult to relate such findings to humans and rabbits.
RABBIT STUDIES
Ocular HSV-1 infection and latency have been extensively studied in New Zealand white rabbits because their eye size is similar to that of humans and slit-lamp examination is relatively easy, allowing quantitative determinations (Table 3 ). In addition, the widespread use of New Zealand white rabbits allows reliable comparisons among studies.
O'Brien and Taylor 21 showed HSV-1 (strain RE) latency by the operational definition in 11% (10 of 88) of male rabbit corneas and in 100% (68 of 68) of male rabbit TG. In this investigation, no cell-free infectious virus was detected in either the cornea or the TG at the time of sacrifice, and the detection technique used was Vero cell culture for corneas and TG.
Zheng et al 23 demonstrated retrograde migration of HSV-1 DNA from latently infected transplanted corneas to the corneal rims and to the TG of 27% (3 of 11) and 18% (2 of 11) of naive uninfected rabbits, respectively. After transcorneal epinephrine iontophoresis, there was no migration if infected with a LAT-negative strain (17DPst, a LAT-negative mutant of 17Syn + ) and successful retrograde migration if the cornea was infected with a LAT+ strain (17Pr, a LAT-positive rescuant of 17DPst). This study confirmed that HSV-1 DNA was present in the corneas of latently infected rabbits and that it was capable of retrograde infection upon adrenergic stimulation. However, latency in the infected transplant donors was established by the absence of corneal lesions by slit-lamp examination and the absence of detectable viral shedding in the tear film by culture. Moreover, it is possible that the infected rabbits did not have true corneal latency at the time of transplantation but that the methods of detection were simply not sensitive enough to identify an early reactivation or a low-grade infection.
Cook and Brown 26 demonstrated HSV-1 (strain 17) latency in sections of corneal epithelium, keratocytes, and endothelium separately in vitro. Latency was established by keeping cultures at a supraoptimal temperature of 41.5°C, and the absence of infectious virus was established by negative cultures and by assays of the culture supernatant at 41.5°C. Reactivation was induced by changing the culture temperature to 37°C, and infectious virus was isolated from 75% (18 of 24), 58% (14 of 24), and 66% (16 of 24) of epithelial, keratocyte, and endothelial cell cultures, respectively. In addition, polyacrylamide gel electrophoresis was used to identify proteins characteristic of acute HSV-1 infection. These proteins were present during incubation at 37°C but absent at 41.5°C. The in vitro method excludes the possibility of ganglionic reactivation because cells were inoculated after microdissection into epithelial, stromal, and endothelial components. Still, corneal latency was not proven because the culture methods used to detect infectious virus may not have been sensitive enough to detect virus at 41.5°C, and persistent virus was observed in 20% (5 of 24) of epithelial cell cultures.
In another study by Cook et al, 27 infectious HSV-1 strains (HG-52, 17, McKrae, and R40/2) were isolated from 12% (4 of 33) of rabbit corneas and 100% (33 of 33) of rabbit TG 56-97 days postinoculation. The rabbits showed no clinically apparent corneal lesions and did not shed infectious virus in tears for 14 days before sacrifice. There was a significant delay in viral growth in corneas compared with that in TG. This delay favors corneal latency and argues against TG reactivation and persistent infection because viral growth would be expected in 2-3 days in the latter 2 cases. 27 Sabbaga et al 28 used in situ hybridization, tear film, whole-cell, and cell-free cultures to demonstrate HSV-1 (strain RE) corneal latency. HSV-1 DNA was detected in 100% (26 of 26) of latently infected corneas by in situ hybridization at 25, 35, 45, and 60 days postinoculation, and TG whole-cell cultures were 75% (12 of 16) positive for infectious virus after induction. Before induction, tear film, whole-cell explants, and cell-free cultures showed no infectious virus in the cornea, and cell-free cultures did not detect infectious virus in the TG. Cell culture techniques have lower sensitivity for detecting HSV-1 than molecular methods (such as PCR or in situ hybridization). 17, 36 However, the use of two different cell culture methods in both the cornea and the TG and three methods overall was convincing in documenting the absence of infectious virus. Another important finding in this experiment was the corneal distribution of HSV-1 DNA detected by in situ hybridization. During the acute infection (up to postinoculation day 9), HSV-1 was detected primarily in the epithelium, with a small amount found in the stromal keratocytes, whereas HSV-1 was detected in the epithelium, stroma, and endothelium in comparable amounts during latent infection (postinoculation days 25-60).
Evidence refuting corneal latency comes from studies that do not sufficiently demonstrate the absence of active infection, do not provide stable copy numbers of corneal HSV-1 DNA and RNA, and do not show reactivation with isolation of infectious HSV-1. Cook et al 17 searched for the presence of LAT and thymidine kinase (TK) DNA and RNA fragments (strains 17 Syn + or McKrae) by PCR in infected rabbit corneas and TG. The rabbits had tear film cultures before sacrifice to assess for infectious virus; all were negative. In the HSV-1 DNA studies, 100% (4 of 4) of ganglia and 60% (3 of 5) of corneas contained HSV-1 TK and ICP-0 genes (LAT antisense). In the RNA studies, LAT was detected in 100% (22 of 22) of ganglia but only in 9% (2 of 22) of corneas, and TK was not detectable in any of the ganglia (22) or corneas (22) tested. These results suggest that corneal latency is equivocal because the corneas (2 of 22) that contained LATs were both from the same rabbit, which was killed 41 days after primary infection with the earliest group of latently infected rabbits. Thus, it is possible that the LAT RNA was residual from the acute infection because LAT is a late transcript in acute disease.
O'Brien et al 29 8) , and 33% (2 of 6) from 20 to 54 weeks. The decreasing frequency of HSV-1 DNA and the absence of LAT in the cornea compared with the high numbers of HSV-1 DNA and LAT in the TG suggest one or both of the following possibilities: (1) corneal latency is less efficient than neuronal latency and/or (2) corneal latency is of a different molecular mechanism or regulatory system than neuronal latency. In addition, the method of confirming the absence of infectious virus during latency was by Vero cells; so, the possibility of a persistent low-grade infection or early reactivation may have been missed and cannot be ruled out as an explanation for the presence of HSV-1 DNA and TK in the cornea. Openshaw et al. 11 established that the cornea can be a reservoir for HSV-1 DNA by transplanting corneas from HSV-1 (strain McKrae) infected rabbits into naive rabbits. The experiment demonstrated that the recipients' corneas maintained similar levels of HSV-1 DNA by PCR 5 months after transplantation. However, reactivation failed even after induction attempts with cyclophosphamide and dexamethasone. For 5 months, the recipient rabbits were negative for tear film cultures and seroconversion. Therefore, the study demonstrated that the rabbit cornea was a reservoir for HSV-1 but failed to show reactivation (ie, recovery of infectious virus), thus failing to prove latency.
In summary, rabbit studies provide excellent evidence for HSV-1 corneal latency including data on HSV-1 migration from the cornea into the corneoscleral rim 23 and on the distribution of HSV-1 DNA in the cornea. 26, 28 However, the available methods for the detection of infectious HSV-1 may not be sensitive enough to detect low-level infection, and studies with promising findings of corneal LAT mRNA or HSV-1 DNA present in stable numbers have failed to rule out active infection or demonstrate reactivation.
NONHUMAN PRIMATE STUDIES
Mice and rabbits have dominated experimental research on ocular herpes because of availability and low cost, but nonhuman primate studies have been performed to establish a connection between the results of nonprimate studies and humans ( Table 4 ). The studies do not test the concept of corneal latency but provide evidence of infectious HSV-1 in monkey corneas.
Varnell et al 45 and 7 of 8 (88%) squirrel monkeys after transcorneal iontophoresis, with 1 primate in each group shedding virus in tears without any prior stimulation. In addition, Rootman et al 46 reported that the average duration of shedding in squirrel monkeys (1.25 days) was 2.75 days shorter than that of rabbits (4.0 days). Also, the corneal epithelial lesions presented about 2 days before the detection of infectious HSV-1 in tears. 46 This finding suggests corneal latency if one assumes that the presence of recurrent corneal lesions indicates the presence of infectious HSV-1. Under this assumption, infectious HSV-1 was present and producing lesions in the corneas 2 days before it was present in the lacrimal glands innervated by the TG.
In summary, infectious HSV-1 has been successfully isolated from the tears of nonhuman primates in the absence of detectable corneal lesions. The recurrence of corneal ulcers before the appearance of infectious HSV-1 in tears suggests that the origin of the HSV-1 is the cornea, rather than the TG.
HUMAN STUDIES
HSV-1 corneal latency has been studied in humans ( Table 5 ) because it relates to PKP and HK. Several reports 12, 13, 47, 48 have documented cases of newly acquired HK after PKP. An important question to be posed is, ''Did HK come from the donor transplanted cornea or from an endogenous reactivation of HSV-1 in the recipient after induction through PKP?'' Remeijer et al 12 herpes is estimated to be 6-14.2 times higher in PKP patients compared with the general population. The detection of HSV-1 in the cornea during HK is important not only to correctly diagnose and treat the condition but also to study the relationship between HK and corneal latency in vivo. 1 The mechanism of HK is thought to be a chronic immune response to either a low-level persistent infection or a series of frequently reactivating subclinical infections. 37 Most of the evidence argues against a chronic low-level infection; so, the question is whether or not the reactivating infections originate in the ganglia or in the cornea.
Tullo et al 1 and Shimeld et al 2 isolated infectious HSV-1 from 6 of 9 and 2 of 3 (66%) patients undergoing PKP for HK, respectively. Coupes et al 4 cultured infectious HSV-1 from 2 of 8 patients (25%) with HK who had no signs of active disease at the time of surgery. The appearance of virus was thought to be transient because the virus was present in one of the samples only on the day of successful isolation. 4 Easty et al 3 isolated infectious HSV-1 from 29.4% (10 of 34) of patients with a clinical history of HK. Two of the corneas that had infectious virus by culture were examined under TEM before culture, and no infectious virions were observed. This finding suggests the absence of infectious HSV-1 but is not definitive as TEM and has a low sensitivity to detect infectious virions. Infectious HSV-1 was only isolated from the central cornea, which favors corneal latency over ganglionic reactivation. Nicholls et al 51 and Beyer et al 52, 53 suggested that the severing of nerve endings during PKP caused reactivation and release of infectious HSV from the TG, with the greatest numbers of virus being found at the graft-host junction. Cantin et al 5 detected the HSV-1 TK DNA sequence by PCR in over 72% (8 of 11) of patients with prior HK and in 36% (4 of 11) of patients without a history of HK. The experiment used PCR to increase the detection sensitivity of HSV-1 DNA from 100 copies to 1 copy. 5 The authors argue that the high frequency of detection of HSV-1 is unlikely to be of ganglionic origin because asymptomatic viral shedding in humans and animals has been shown to occur in about 10%-30% (not .70%) of corneas with a history of herpetic disease. 5, 17 The transmission of HSV-1 through PKP is 1 way to suggest corneal latency, but the presence of HSV-1 DNA and mRNA transcripts in asymptomatic corneas must also be evaluated. Openshaw et al 11 detected HSV-1 DNA sequences for both TK and glycoprotein D (gD) in 9 of 24 clinically normal eye bank corneas (38%), whereas Robert et al 31 showed HSV-1 DNA by PCR in 21% (8 of 38) of asymptomatic patients who underwent PKP for nonherpetic disease. van Gelderen et al 32 detected HSV-1 DNA sequences for TK in the recipient corneas of 13 of 78 patients (17%) who underwent PKP for reasons unrelated to HK, including 8 failed corneal transplants without apparent herpetic disease before surgery. Kaye et al 33 demonstrated the presence of 3 different HSV-1 DNA sequences in the recipient corneas of 5 of 10 nonherpetic PKP patients (50%), of which 3 (30%) also contained LAT as the only RNA viral transcript present. These studies demonstrate that HSV-1 DNA and RNA are frequently present in asymptomatic corneas. In the last study, the detection of 3 widely spaced HSV-1 DNA sequences in the viral genome implies the presence of the entire DNA genome. 33 The discovery of LAT as the only abundant RNA transcript makes it unlikely that a persistent infection or a reactivation of the TG is responsible for these findings.
In the only human study involving denervation, Hoyt and Billson 19 reported recurrent fever blisters after complete transection of the infraorbital nerve after blowout fracture. This approach eliminated the possibility of TG reactivation and demonstrated that HSV can survive and reactivate without the support of the TG. The above studies present a strong case for corneal latency, but there is still a possibility that the PKP recipients either had undetectable HK and/or HSV-1 DNA in their corneas because of reactivation of endogenous HSV-1 or a transient viral presence.
In a study of 450 recipient corneal buttons, 273 donor corneoscleral rims, and 84 clear eye bank corneas, Remeijer et al 48 showed that increased corneal HSV-1 viral loads correlated with an increased risk of graft failure in patients with HK after PKP but did not negatively influence graft survival in patients without HK undergoing PKP. In an editorial commentary on this study, Hill and Clement 22 pointed out that the HSV-1 DNA copy numbers found in patients with HK were approximately 100 times greater than those found in patients without HK. However, this observation suggests only that corneal graft failures contained higher numbers of HSV-1 DNA copies. It does not reveal any information about the origin of the HSV-1 DNA found in the cornea.
Remeijer et al 48, 50 argue that surgical trauma, suture removal, steroids, and immune reactions associated with PKP could trigger endogenous reactivation of HSV-1, resulting in viral DNA or possibly infectious HSV-1 in the cornea. The innervations of the cornea are 300-600 times higher than those of the skin; so, disruption of these nerves during PKP can provide a strong stimulus for reactivation. 47 Also, many of the patients who developed newly acquired HK after PKP were seropositive for HSV-1 and received corneal transplants that were negative for HSV-1 by PCR. 48 In a study with 10 nonherpetic corneas, Kaye et al 33 noted that several viral genes and LAT were present, but none of the ''latent'' corneas underwent successful reactivation, that is, no detectable infectious virus. Additionally, the study by Openshaw et al 11 suggested that viral detection was greater in the periphery of the cornea than in the central cornea with 33% (8 of 24) and 8% (2 of 24) found in each area, respectively. Openshaw et al's study found more virus in the periphery of the corneas than in the central cornea areas. That finding supports the theory that the trigeminal ganglia (TG) are the source of viral shedding. The question in this paper is whether the cornea also harbors latent HSV-1 virus. The Openshaw study implies that the TG is responsible for the latent virus found in the cornea.
CELL TYPES IN CORNEA AS A SITE OF LATENCY
Most studies involving the molecular biology of HSV latency used ''whole cornea.'' However, Cook and Brown 26 showed that all 3 cell types in latent rabbit corneas, that is, the corneal epithelium, keratocytes, and endothelial cells, had the characteristics of HSV-1 latency. There have been very limited studies on human endothelial cells and these seem to be an unlikely although possible source of HSV-1 latency. More importantly, because the corneal epithelial cells are highly innervated, the nerve termini are a likely source of HSV-1 DNA. Numerous studies have shown virus particles and HSV-1 DNA in stromal keratocytes. Stromal cells are also highly innervated with nerve terminals that originate from the TG. Thus, both cell types could harbor latent HSV-1 DNA. Conversely, one could argue that all of the measurements of the positive characteristic of HSV-1 in cornea are not because of ''true'' viral latency but are endpoints of the transport of the virus from ganglionic nerve terminals to the ocular surface.
HSV-1 CORNEAL LATENCY VERSUS HSV-1 NEURONAL LATENCY (SUMMARY)
All researchers agree that ganglionic neurons are a site of HSV-1 latency. Many studies on TG from rabbits, mice, nonhuman primates, and humans have provided evidence for this fact. However, there is a controversy concerning the cornea as a site of latency. Our hypothesis is that HSV-1 is latent in human corneas. One reason is that infectious virus was recovered in some studies from corneal cultures. Additionally, transplanted corneas have been shown to transmit HSV-1. 12, 13, 22 Molecular biological studies of the cornea have shown the presence of HSV-1 DNA and HSV-1 transcripts, specifically the LAT transcript. Some studies have found latent HSV-1 in the cornea. The test results that can be interpreted to indicate that there is HSV-1 DNA in the TG can also be interpreted that there is HSV-1 DNA in the cornea.
CONCLUSIONS
HSV-1 corneal latency has long been an important topic. Our hypothesis is that HSV-1 is latent in human corneas. Other possibilities such as persistent low-grade infection and trigeminal reactivation with downstream shedding to the cornea cannot be absolutely ruled out. It is unlikely that operational latency in the cornea will ever be definitively proven unless a new method with higher sensitivity for the detection of infectious virus in the cornea is developed. Nevertheless, it is important to study the HSV-1 disease progression and the real possibility of the existence of corneal latency to improve our understanding of these processes. This knowledge should lead to more effective treatments for HK and decreased graft failures after PKP.
